Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Hypogonadotropic HypogonadismProlactinoma
Interventions
DRUG

Clomiphene citrate

Clomiphene 50 mg/day for 12 weeks

Trial Locations (1)

09541-330

Neuroendocrine Unit - Escola Paulista de Medicina (UNIFESP), São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER

NCT00697814 - Clomiphene in Males With Prolactinomas and Persistent Hypogonadism | Biotech Hunter | Biotech Hunter